Sudden enlargement of local recurrent thyroid tumor after recombinant human TSH administration

被引:60
作者
Braga, M
Ringel, MD
Cooper, DS
机构
[1] Sinai Hosp, Div Endocrinol & Metab, Baltimore, MD 21215 USA
[2] Univ Fed Parana, Hosp Clin, Serv Endocrinol & Metab Parana, BR-80060240 Curitiba, Parana, Brazil
[3] Washington Hosp Ctr, Endocrinol Sect, Washington, DC 20010 USA
[4] Medstar Res Inst, Washington, DC 20010 USA
[5] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
关键词
D O I
10.1210/jc.86.11.5148
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chronic endogenous TSH stimulation of neoplastic tissue has been reported to stimulate tumor enlargement. However, little is known about changes in normal and neoplastic thyroid tissue after sudden rather than chronic stimulation with TSH. Acute thyroidal tissue reactions, reflected by rapid tumor expansion and/or possible vascular changes, have been reported to occur after bovine TSH stimulation and, more recently, after recombinant human TSH (rhTSH). In this report, we describe two patients with papillary thyroid carcinoma with local recurrent tumor. Both patients developed tumor growth 12-48 h after the second rhTSH injection, reflected by acute respiratory distress or a palpable, tender mass. In both situations, the enlargement was documented by imaging techniques, showing tumor expansion compared with previous examinations. Rapid improvement with glucocorticoid supports inflammation as the likely etiology. Based on these cases, and other reports of rapid tumor expansion after rhTSH injection, we recommend glucocorticoid coverage before rhTSH administration for patients with known or suspected neoplasia located in a limited space.
引用
收藏
页码:5148 / 5151
页数:4
相关论文
共 16 条
[1]   Prognosis and treatment of brain metastases in thyroid carcinoma [J].
Chiu, AC ;
Delpassand, ES ;
Sherman, SI .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) :3637-3642
[2]   THYROID-CARCINOMA WITH SPINAL-CORD COMPRESSION [J].
GOLDBERG, LD ;
DITCHEK, NT .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 245 (09) :953-954
[3]   A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer [J].
Haugen, BR ;
Pacini, F ;
Reiners, C ;
Schlumberger, M ;
Ladenson, PW ;
Sherman, SI ;
Cooper, DS ;
Graham, KE ;
Braverman, LE ;
Skarulis, MC ;
Davies, TF ;
DeGroot, LJ ;
Mazzaferri, EL ;
Daniels, GH ;
Ross, DS ;
Luster, M ;
Samuels, MH ;
Becker, DV ;
Maxon, HR ;
Cavalieri, RR ;
Spencer, CA ;
McEllin, K ;
Weintraub, BD ;
Ridgway, EC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (11) :3877-3885
[4]   RECOMBINANT HUMAN THYROID-STIMULATING HORMONE - INITIAL BIOACTIVITY ASSESSMENT USING HUMAN FETAL THYROID-CELLS [J].
HUBER, GK ;
FONG, P ;
CONCEPCION, ES ;
DAVIES, TF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 72 (06) :1328-1331
[5]   Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma [J].
Ladenson, PW ;
Braverman, LE ;
Mazzaferri, EL ;
BruckerDavis, F ;
Cooper, DS ;
Garber, JR ;
Wondisford, FE ;
Davies, TF ;
DeGroot, LJ ;
Daniels, GH ;
Ross, DS ;
Weintraub, BD .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (13) :888-896
[6]  
LADENSON PW, 2000, THYROID TODAY, V23, P1
[7]   UNUSUAL THYROID RESPONSES TO THYROTROPIN STIMULATION [J].
LEVEY, GS ;
SODE, J ;
GORDEN, P .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1968, 28 (06) :909-+
[8]   Radioiodine treatment of metastatic differentiated thyroid cancer in patients on L-thyroxine, using recombinant human TSH [J].
Lippi, F ;
Capezzone, M ;
Angelini, F ;
Taddei, D ;
Molinaro, E ;
Pinchera, A ;
Pacini, F .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 144 (01) :5-11
[9]   Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma [J].
Luster, M ;
Lassmann, M ;
Haenscheid, H ;
Michalowski, U ;
Incerti, C ;
Reiners, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3640-3645
[10]  
MALOOF F, 1956, J CLIN ENDOCR METAB, V16, P1